We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Incidence of hepatitis C virus infection among people living with HIV: An Egyptian cohort study.
- Authors
Elrashdy, Fatma; Hagag, Suzan; Mohamed, Rahma; Alem, Shereen Abdel; Meshaal, Safa; Cordie, Ahmed; Elsharkawy, Aisha; Esmat, Gamal
- Abstract
Background: Egypt used to have one of the highest hepatitis C virus (HCV) infection prevalence rates worldwide, with an estimated HCV prevalence of around 4.5% to 6.7%. Objectives: To determine the HCV infection incidence rate amid Egyptian patients living with HIV. Method: A total of 460 HIV-positive patients were recruited in a retrospective cohort study from Imbaba Fever Hospital, Cairo, between January 2016 and March 2019. The patients had a negative baseline and at least one other HCV antibody test. Hepatitis C virus antibody testing was done by antibody sandwich third-generation enzyme-linked immunosorbent assay. The hepatitis C virus infection incidence rate among HIV-infected patients was calculated using the person-time incidence rate. Results: Two hundred and eighteen patients were finally included: 146 (31.7%) patients were excluded for having a positive baseline HCV Ab result and 96 patients were excluded for not having a follow-up HCV Ab test. Eighteen patients had HCV seroconversion (8.3%), achieving an incidence rate of 4.06 cases per 100 person-years (95% confidence interval: 3.87–4.24). Injection drug use (IDU) was the commonest risk factor among seroconverters, with an HCV incidence rate of 7.08 cases per 100 person-years. Injection drug use history was reported in 83.3% of the seroconverters and in only 47.2% of non-seroconverters; P = 0.005. Conclusion: Egyptian HIV-infected patients show a high incidence rate of HCV infection especially among those who have a history of IDU. Accordingly, attention should be paid for prevention, screening and timely treatment of HCV in patients infected with HIV.
- Subjects
EGYPT; CAIRO (Egypt); HIV-positive persons; HIV seroconversion; HEPATITIS C; DRUG abuse; HEPATITIS C virus; ENZYME-linked immunosorbent assay; EGYPTIANS
- Publication
Southern African Journal of HIV Medicine, 2022, Vol 23, Issue 1, p1
- ISSN
1608-9693
- Publication type
Article
- DOI
10.4102/sajhivmed.v23i1.1442